Document is current

Article History

Received: 22 July 2022

Accepted: 15 November 2022

First Online: 27 November 2022

Declarations

:

: The authors have no relevant financial or non-financial interests to disclose.

: GenIDA satisfies all ethical requirements: the research is carried out in accordance with the provisions of the French Data Protection Act (French law of 6 January 1978, amended by the law of 6 August 2004 on the protection of individuals regarding the processing of personal data), and complies with the General Data Protection Regulation 2016/679 (GDPR). The study has been declared to the French Commission on Information Technology and Liberties on 27/11/2015, number 1907912v0. It has been reviewed and approved by the Ethics Evaluation Committee of INSERM—Institut National de la Santé Et de la Recherche Médicale—(IORG0003254, FWA00005831), the Institutional Review Board (IRB00003888) of the French Institute of Medical Research and Health on 15/11/2016, number 16–338, and on 04/09/2019, number 16–338 bis. Participants are asked to read the information note and to give their informed consent before accessing any questionnaire on the GenIDA website (general questionnaire, Covid-19 related lockdown questionnaire, etc.). This consent form details the terms and conditions of participation in the GenIDA research. It specifies that participation is free and that the agreement to participate can be withdrawn at any time, without justification of any kind, simply by logging back into one's account on the GenIDA website. Hence, informed consent is obtained from all participants to the GenIDA studies, i.e., either the subject him/herself or his/her relative responding to the study on behalf of the person with ID (parent or legal guardian(s)).